On behalf of Conference Series LLC Scientific Committee Members, we invite the worldwide global audience and presenters to participate at the 2^nd International Conference on Metabolic Syndrome which is to be held in Paris, France during 11-12 September 2017. Special interest and theme of the conference is ‘Innovative Technologies and Treatments to overcome Metabolic Syndrome and offer lasting lifestyle’.

Metabolic syndrome is a clustering of abnormalities characterised by the association of insulin resistance/type 2 diabetes, hyperlipidaemia, hypertension, and abdominal obesity. Advances in scientific research, the increasing prevalence of obesity, and the disorder’s role in contributing to cardiovascular disease and diabetes are fuelling interest in metabolic syndrome. The most important risk factors are diet, genetics, stress, aging, sedentary behaviour or low physical activity, disrupted chronobiology/sleep, mood disorders/psychotropic medication use, and excessive alcohol use.

Recently, the Consensus Panel International Diabetes Federation (IDF) proposed a new definition for the Metabolic Syndrome that emphasises the importance of central obesity. The European Global Cardiometabolic Risk Profile in Patients with Hypertension Disease survey investigated the cardiometabolic risk profile in adult patients with hypertension across 289 locations in four European regions. A study assessing data collected between 1997 and 2003 reported that the prevalence of obesity, defined as body mass index, varied between 6% and 20%, with higher prevalence in Central and Eastern European countries and lower values in France, Italy and some Scandinavian countries. With the exception of the Italian, Norwegian and UK cohorts, the prevalence of obesity was much higher in the European populations that were reported in the most recent review addressing the distribution of obesity in Europe. National US survey data suggest the Metabolic Syndrome affects about one-quarter of adults aged 20 to 70 years, with the prevalence approaching 50% in the elderly.

Conference Series LLC organises a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30,000 eminent personalities, reputed scientists as editorial board members

Why to attend?

Metabolic Syndrome 2017 highlights the theme ‘Innovative Technologies and Treatments to overcome Metabolic Syndrome and offer lasting lifestyle’ Which focus on the latest advancements in prevention and treatment cure of various metabolic diseases which are occurring due to one or another metabolic malfunctioning.

Metabolic Syndrome 2017 provides two days robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts on a global scale. This two day event provides a perfect platform for leading scientists, researchers, scholars, practitioners, health care experts, treatment providers, equipment and diagnostic tools manufacturers/vendors, to gain knowledge about the latest advancements in clinical research and health diagnostics within the respective field and also encourages new innovations, research ideas around the globe.